問卷

TPIDB > Principal Investigator

Principal Investigator


Linkou Chang Gung Medical Foundation (在職)

Division of Ophthalmology

更新時間:2023-09-19

陳賢立Chen, Xian-Li
  • Principal Investigator
  • Clinical Trial Experience (year) 17 years 9 個月
  • chen0927@cgmh.org.tw

篩選

List

4Cases

2009-06-01 - 2010-09-30

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites

2011-09-01 - 2013-05-31

Phase III

Efficacy and Safety of Brinzolamide 10 mg/mL / Brimonidine 2 mg/mL Eye Drops, Suspension Compared to Brinzolamide 10 mg/mL Eye Drops, Suspension plus Brimonidine 2 mg/mL Eye Drops, Solution in Patients with Open-Angle Glaucoma or Ocular Hypertension
  • Condition/Disease

    Open-Angle Glaucoma or Ocular Hypertension

  • Test Drug

    Brinzolamide 10 mg/mL/Brimonidine 2 mg/mL Fixed Combination Eye Drops, Suspension

Participate Sites
2Sites

Terminated2Sites

2008-11-01 - 2010-06-30

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites

2008-11-01 - 2011-06-30

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites